[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

May 29, 2026

Up to $250,000 USD per proposal; multiple awards possible; actual funding may vary from request.

Supports independent educational initiatives to improve clinical decision-making and patient outcomes in transthyretin-mediated amyloidosis (ATTR-CM).

Applications must be submitted via the Alnylam grants portal; only eligible organizations may apply (not individuals or practice groups).

--- ## Description This opportunity supports independent, high-impact educational activities that address gaps in the screening, diagnosis, monitoring, and management of transthyretin-mediated amyloidosis (ATTR-CM). Programs should be designed to enhance real-world clinical decision-making and equip healthcare professionals with actionable knowledge and tools. The focus is on evidence-based, practical education that can be implemented in routine practice, with priority given to proposals addressing disease biology, early diagnosis, treatment decisions, long-term management, multidisciplinary care, and emerging therapies. --- ## Due Dates - May 29, 2026: Submission Deadline for RFP ALNY-RFP-TTR-13 (Advancing Clinical Decision-Making in ATTR-CM) --- ## Funding Amount - Individual proposals may be awarded up to **$250,000 USD**. - Multiple awards may be made for different venues or channels. - The amount funded may be less than requested; applicants are encouraged to seek multiple funding sources. - Funding cannot be used for meals for attendee HCPs. --- ## Eligibility - **Eligible applicants:** - Professional associations - Patient advocacy organizations - Healthcare institutions - Medical education companies (must be ACCME-accredited, and the accredited provider must submit the request) - Other organizations dedicated to healthcare improvement - **Not eligible:** - Individuals (including individual healthcare providers) - Healthcare provider practice groups or provider-owned clinics - Managed care organizations and pharmacy benefit managers - **Additional requirements:** - Activities must comply with legal and regulatory standards. - Proof of tax status is required. - Application must be submitted at least 45 days before the intended project start date. --- ## Application Process - All requests must be submitted through the [Alnylam grants portal](https://alnylam-grants.steeprockinc.com) or via the [corporate website](https://www.alnylam.com/about-alnylam/grants-and-giving). - Required materials include: - Comprehensive needs assessment/gap analysis - Detailed project plan and timeline - Budget breakdown with justification - Description of educational design and learning objectives (SMART) - Accreditation documentation (if applicable) - Plans for recruitment, evaluation, outcomes reporting, and sustainability - Applications are reviewed by the Alnylam Grants and Giving Office; applicants will be notified by email. - All funded activities must acknowledge Alnylam’s support and comply with transparency requirements. - For CME activities, reconciliation is required within 90 days of program completion. --- ## Additional Information - Proposals may target U.S. and/or global audiences, including specialists (cardiologists, cardiac imaging, clinical pharmacists, etc.) involved in ATTR-CM care. - Educational activities may be delivered via symposia at major cardiology congresses, digital CME platforms, or live regional/national programs. - Content must be balanced, evidence-based, and free from commercial bias. - Multiple proposals or multi-venue submissions are allowed but must clearly delineate budgets and objectives. - Alnylam reserves the right to fund discrete components of multi-venue proposals. --- ## External Links - [RFP Details: Advancing Clinical Decision-Making in ATTR-CM (PDF)](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-13%20Advancing%20Clinical%20Decision-Making%20in%20ATTR-CM.pdf) - [Alnylam Grants and Giving Program Overview](https://www.alnylam.com/about-alnylam/grants-and-giving#charitable-donations) - [Alnylam Grants Portal – Submit Application](https://alnylam-grants.steeprockinc.com) --- ## Contact Information | Purpose | Contact | |-----------------|------------------------------------------------------| | General/RFP | [grants@alnylam.com](mailto:grants@alnylam.com) | | Funder Website | [Alnylam Pharmaceuticals](https://www.alnylam.com/contact) |

Grants and Giving

Sign in to see full grant listing